Attention-Deficit Hyperactivity Disorder (ADHD) Study With Adults
Public ClinicalTrials.gov record NCT00048360. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An 8-week, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Flexible-Dose Comparison of Extended-Release Bupropion Hydrochloride 300-450 mg/Day to Assess the Efficacy, Safety, and Effects on Health Outcomes in the Treatment of Adults With Attention-Deficit/Hyperactivity Disorder
Study identification
- NCT ID
- NCT00048360
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- GlaxoSmithKline
- Industry
- Enrollment
- 162 participants
Conditions and interventions
Conditions
Interventions
- Extended-release bupropion hydrochloride Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 60 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 30, 2002
- Primary completion
- May 31, 2003
- Completion
- May 31, 2003
- Last update posted
- Feb 11, 2013
2002 – 2003
United States locations
- U.S. sites
- 21
- U.S. states
- 14
- U.S. cities
- 21
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| GSK Clinical Trials Call Center | Phoenix | Arizona | 85016 | — |
| GSK Clinical Trials Call Center | Chula Vista | California | 91910 | — |
| GSK Clinical Trials Call Center | Lafayette | California | 94549 | — |
| GSK Clinical Trials Call Center | Northridge | California | 91324 | — |
| GSK Clinical Trials Call Center | Spring Valley | California | 91978 | — |
| GSK Clinical Trials Call Center | West Palm Beach | Florida | 33407 | — |
| GSK Clinical Trials Call Center | Paducah | Kentucky | 42003 | — |
| GSK Clinical Trials Call Center | Rockville | Maryland | 20852 | — |
| GSK Clinical Trials Call Center | Cambridge | Massachusetts | 02138 | — |
| GSK Clinical Trials Call Center | Worcester | Massachusetts | 01655 | — |
| GSK Clinical Trials Call Center | Omaha | Nebraska | 68105 | — |
| GSK Clinical Trials Call Center | Chapel Hill | North Carolina | 27514 | — |
| GSK Clinical Trials Call Center | Beachwood | Ohio | 44122 | — |
| GSK Clinical Trials Call Center | Cincinnati | Ohio | 45267-0559 | — |
| GSK Clinical Trials Call Center | Portland | Oregon | 97209 | — |
| GSK Clinical Trials Call Center | Bellaire | Texas | 77401 | — |
| GSK Clinical Trials Call Center | Houston | Texas | 77007 | — |
| GSK Clinical Trials Call Center | Salt Lake City | Utah | 84132 | — |
| GSK Clinical Trials Call Center | Burlington | Vermont | 05405 | — |
| GSK Clinical Trials Call Center | Woodstock | Vermont | 05091 | — |
| GSK Clinical Trials Call Center | Seattle | Washington | 98104 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00048360, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 11, 2013 · Synced May 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00048360 live on ClinicalTrials.gov.